B2B ad examples

We’re skipping the booth at #ESMO2026. Instead, we’re bringing Aika 2.0 directly to you.🏎🔥 From October 24-26, eligible attendees can 𝗯𝗼𝗼𝗸 𝗽𝗿𝗶𝘃𝗮𝘁𝗲 𝗿𝗶𝗱𝗲𝘀 across Madrid and experience Aika 2.0 live: 👉 One operating system with modular capabilities 👉 From IND to market approval 👉 Every decision fully connected Clinical development is on the move. Book your ride with us 🤝 : https://lnkd.in/eX2w34Bx

Reading from home typically means logging into a VPN, waiting on images to download, and working on a viewer that never quite matches the reading room. The StreamVue Enterprise Radiology Viewer streams the study instead, so a satellite site gets the same speed as the main campus. It layers onto the PACS you already have, so there is no migration project to deploy.

“Het is niet zo dat iemand automatisch weer gaat leven als hij stopt met overleven.” Deze visie op ACT loopt als een rode draad door het werk van Tim Batink. Als klinisch psycholoog, ACT-opleider, onderzoeker en medeontwikkelaar van het ACT-programma van Embloom houdt hij zich al jarenlang bezig met de ontwikkeling, toepassing en wetenschappelijke onderbouwing van ACT binnen de ggz en e-health. Volgens Tim draait herstel om leren omgaan met moeilijke gedachten en gevoelens, terwijl iemand tegelijkertijd blijft investeren in wat belangrijk is in het leven. Vanuit die visie werkte hij samen met Embloom aan de vernieuwing van het ACT-programma. Met nieuwe oefeningen, metaforen, simpeler en toegankelijker taalgebruik, en een boostermodule sluit het programma nog beter aan bij de dagelijkse praktijk van behandelaren en cliënten. In onze blog vertelt Tim: 🟠Hoe ACT cliënten helpt om flexibeler om te gaan met angst, somberheid en lichamelijke klachten 🟠Waarom ACT momenteel zo breed wordt ingezet binnen de ggz. 🟠Hoe e-health cliënten ondersteunt om ook buiten de behandelkamer actief met herstel bezig te zijn. Lees de blog: https://lnkd.in/etpY9Nrj

From cytokine release syndrome to long-term follow-up, CGTs introduce unique safety challenges. Learn why pharmacovigilance needs to start earlier and play a more strategic role.

Get tips for addressing key CGT challenges.

Say goodbye to surprise fees. With TheraNest® Premier, you get 500 claims per therapist, no tip required - and just one straightforward monthly bill.

You may see bioprocessing filtration products labeled under Solventum, 3M, or Thermo Scientific as branding updates progress, while products remain the same.

Will your lab be ready for the next outbreak? Now may be the time to bring testing in-house.

See how educators are using Lt to create engaging, hands-on learning experiences.

Level up your teaching materials with 10 free human physiology images! ✅ Clear & accurate ✅ Designed by experts ✅ Make complex physiology concepts easier to understand.

Up to 50% of Malaysian outpatient claims are for minor, treatable illnesses. Why pay high panel fees when you can cover 24/7 doctor consultations, instant prescriptions, and medication delivery for just RM24/employee/month? No setup fee, fully digital, and HRD Corp claimable. Let's optimize your 2027 benefits today.

Up to 50% of Malaysian outpatient claims are for minor, treatable illnesses. Why pay high outpatient fee when you can cover 24/7 teleconsultations, instant GP prescriptions, and medication delivery for just RM24/employee/month? No setup fee, fully digital, and HRD Corp claimable. Let's optimize your 2027 benefits today.

Novel antibody formats are multiplying fast, but most data infrastructure hasn’t kept pace. Your years of antibody data end up unstructured, and AI models have nothing to learn from. At #PEGSEurope, I’ll show how we close the gap, giving antibody teams a shared, structured foundation to design, characterize, register, and learn from proteins, and what that means for the speed of your DBTL cycles. Join my session on Tuesday, Nov 17 at 12:15 PM and visit our booth #421! 🔗 View the session details: https://lnkd.in/eHWQY4nb

Now Open in Pensacola: Same-day injury care, real-time reporting, OSHA compliance, & return-to-work support—built for employers.

Fast, reliable drug testing. Streamlined programs. Compliance support to reduce risk, make testing easier to manage, and keep operations moving.

Meet Eclipsebio at the International mRNA Health Conference in Boston, November 17-19, 2026. Don’t miss our talk, “Lab-in-the-Loop: Closing the Design-Build-Test Gap in mRNA Development,” on November 19, 9:40-9:45 AM. Let’s talk RNA!

Your members deserve easy access to hearing care. Your plan deserves a higher ROI. Stop by Booth #535 at IFEBP to learn more.

Bring your hardest imaging problem to Chicago... Planning a PACS change, cloud move, site expansion, AI adoption, or a rethink of imaging costs? Bring it to Booth 2968 at RSNA 2026. Use 30 minutes with the AdvaHealth team to pressure-test what you’re planning, what’s getting in the way, and what you want imaging to look like next. Workflow. Cloud. AI. System sprawl. Access. Cost and licensing. Make the conversation about your imaging environment. Book 30 minutes with us at RSNA

The countdown to #AAHKS2026 has begun! Explore the latest in our hip and knee procedural solutions, take part in educational programs and hands-on learning, and connect with our team. Visit us at booth #1105 and view the full agenda: https://lnkd.in/eFmKNNpC

“When I’m at work, I’m able to be 100% there. And when I’m at home, I’m able to be 100% with my family.” Dr. Schammel practices dermatology at CentraCare. Physicians tell us the same thing again and again: they want to be fully present at work and fully present at home, and too often one comes at the cost of the other. Practice medicine in central Minnesota → https://lnkd.in/gShjPBhY

Bristol Myers Squibb teams are scaling imaging AI initiatives across oncology and neuroscience research, but fragmented imaging workflows can slow progress. Explore Flywheel resources focused on AI-ready datasets, multicenter imaging harmonization, and scalable research infrastructure.

Your 2027 cash forecasts depend on exemption status across your SUD programs. Get the answer before budgets lock.

Multicenter studies at Bristol Myers Squibb require scalable imaging workflows that reduce operational complexity and support reproducible AI-driven research. See how Flywheel helps enterprise biopharma teams centralize imaging operations, standardize datasets, and accelerate imaging AI initiatives at scale.

Clinical trial activity faced significant headwinds in 2025, with completed studies declining 11% year over year. Yet beneath the surface, success rates improved, positive pivotal trials increased and late-stage momentum continued in key therapeutic areas such as oncology and metabolic disease. Explore the data, trends and sponsor performance shaping the future of clinical development in Citeline’s Annual Completed Clinical Trials Report.